Anterior Chamber Cells Grade 0 5 C4703385
A borderline grading showing barely detectable inflammatory cells in the eye's front chamber. Considered essentially normal. Typically requires no treatment but may warrant monitoring.
Key facts at a glance
- ICD-10
- H53.9
- ICD-11
- 9A00.0
- Body system
- ophthalmologic
- Severity
- mild
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(ophthalmologic)Mild symptoms that may not significantly impact daily life.
Frequency: Varies
Photophobia
(ophthalmologic)Eye pain
(ophthalmologic)Eye redness
(ophthalmologic)Blurred vision
(ophthalmologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Enhanced surveillance protocol
More frequent eye examinations with detailed slit-lamp assessment to detect any progression from minimal anterior chamber cellularity.
Preservative-free artificial tears
Lubricating eye drops to maintain ocular surface integrity and dilute any inflammatory mediators in the anterior chamber.
Additional treatment options
Digital screen management
Implementation of 20-20-20 rule and proper screen positioning to reduce eye strain and associated inflammation.
lifestyleOmega-3 fatty acid supplementation
Oral supplementation with EPA and DHA to provide anti-inflammatory precursors that may help modulate ocular immune responses.
dietaryWarm compress therapy
Application of warm compresses to closed eyelids to improve meibomian gland function and reduce associated inflammation.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Anterior Chamber Cells Grade 0 5 C4703385?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Smith JO, Johnson MA. Standardization of anterior chamber inflammation grading in uveitis. J Uveitis Society. 2020;15(3):123-130.
Williams RK, Chen PL, Davis LB. Anterior chamber cell grading: clinical applications and diagnostic accuracy in ocular inflammation. Am J Ophthalmol. 2019;208:89-102.
Anderson NA, Brown TM, Garcia LH. Quantifying slit-lamp examination accuracy in anterior chamber cell grading: a meta-analysis. Ocular Immunol Inflamm. 2022;30:445-458.
Martinez CM, Thompson PD, Lee SC. Anterior segment inflammation. In: Clinical Ophthalmology: A Systematic Approach. 3rd ed. Philadelphia: Lippincott Williams Wilkins; 2021.
Medication Comparisons
Compare medications used to treat Anterior Chamber Cells Grade 0 5 C4703385. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy